«What in longevity science survives contact with data?»
The biology of ageing, biomarkers, clinical trials and the industry of promises. Telling longer healthy life apart from the sale of hope.
The longevity market is growing faster than the evidence under it.
Some interventions extend healthy life in model animals; biomarkers are being standardised.
Whether the results carry over to humans, and whether “biological age” means anything.
The gap in healthy life expectancy makes this a social question.
Names are published only after written confirmation of participation. The line-up may change; ticket holders hear about changes first.